$17.98
+0.98 (+5.73%)
At Close: Jun 03, 2026
Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer
07:30am, Tuesday, 08'th Jul 2025
Seasoned Leader Brings Deep Experience in Oncology Drug Development as Company Advances Portfolio of Next Generation Therapeutics for Solid Tumors
Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million
07:00am, Monday, 16'th Jun 2025
Advancing Lead Program, CR-001, a PD-1 x VEGF Bispecific Antibody, and Developing Pipeline of Novel ADCs as Single Agents and in Combination with CR-001
The combined company will operate as “Gyre Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “GYRE” effective Tuesday, October 31, 2023
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the merger of Catalyst Bioscience
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBIO, ANGN, AQUA, OSH
02:28pm, Thursday, 23'rd Mar 2023
NEW YORK, March 23, 2023 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breache
SHAREHOLDER ALERT: Weiss Law Reminds DCP, MLVF, SHBI, and CBIO Shareholders About Its Ongoing Investigations
02:41am, Tuesday, 07'th Mar 2023
NEW YORK , March 7, 2023 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights
Why Is Catalyst Biosciences (CBIO) Stock Up 55% Today?
08:00am, Tuesday, 28'th Feb 2023
Catalyst Biosciences (NASDAQ: CBIO ) stock is rocketing higher on Tuesday after the company announced an asset purchase agreement with GC Biopharma. That agreement has Catalyst Biosciences selling thr
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating Catalyst Biosciences, Inc. (Nasda
CBIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Catalyst Biosciences, Inc. Is Fair to Shareholders
07:23am, Wednesday, 28'th Dec 2022
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Catalyst Biosciences, Inc. (NASDAQ: CBIO) and GNI Group Ltd. is fair to Catalyst shareh
Catalyst Biosciences: Shareholders Should Reap Benefits From Owning The Stock
12:23pm, Monday, 15'th Aug 2022
Catalyst Biosciences is highly committed to its cash distribution plan to shareholders of up to $65 million in the near future, with only a $58 million market capitalization. If the proxy contest is c
JDS1, LLC Terminates Proxy Contest at Catalyst’s 2022 Annual Meeting
06:00am, Thursday, 11'th Aug 2022
FORT LEE, N.J.--(BUSINESS WIRE)--JDS1, LLC (“JDS1”), which collectively with the other reporting persons in its Section 13(d) group, beneficially owns approximately 8.4% of the outstanding common
JDS1, LLC Files Definitive Proxy Statement and Sends Letter to Catalyst Stockholders
12:21pm, Friday, 22'nd Jul 2022
FORT LEE, N.J.--(BUSINESS WIRE)--JDS1, LLC, which collectively with the other participants in its solicitation beneficially owns approximately 8.4% of the outstanding common stock of Catalyst Bioscien
Has Catalyst Biosciences (CBIO) Outpaced Other Medical Stocks This Year?
10:50am, Tuesday, 28'th Jun 2022
Here is how Catalyst Biosciences, Inc. (CBIO) and Humana (HUM) have performed compared to their sector so far this year.
5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now?
11:03am, Friday, 17'th Jun 2022
Penny stocks are red hot right now if you know where to… The post 5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now? appeared first on Penny Stocks to Buy, Picks, News and Informa
Hot Penny Stocks to Buy This Week? 3 to Watch
08:21pm, Wednesday, 25'th May 2022
Which penny stocks are you watching right now? The post Hot Penny Stocks to Buy This Week?
Sign In
Buy CBIO